Abstract:Recombinant prion protein (PrP) assemblies from different primary mammalian structures can transmit and exhibit divergent adaptation processes and strain properties over passaging in transgenic mice expressing hamster PrP, mimicking genuine prions evolutionary properties across species barriers. Structurally, these prions contained pathological PrP lacking the N‐terminal region thought to be crucial for infectivity. These findings enhance our understanding of prion transmission, adaptation, and the structural characteristics of prion strains. Mammalian prions are neurotropic pathogens formed from PrPSc assemblies, a misfolded variant of the host‐encoded prion protein PrPC. Multiple PrPSc conformations or strains self‐propagate in host populations or mouse models of prion diseases, exhibiting distinct biological and biochemical phenotypes. Constrained interactions between PrPSc and PrPC conformations confer species specificity and regulate cross‐species transmission. The pathogenicity of fibrillar assemblies derived from bacterially expressed recombinant PrP (rPrP) has been instrumental in demonstrating the protein‐only nature of prions. Yet, their ability to encode different strains and transmit between species remains poorly studied, hampering their use in exploring structure‐to‐strain relationships. Fibrillar assemblies from rPrP with hamster, mouse, human, and bovine primary structures were generated and tested for transmission and adaptation in tg7 transgenic mice expressing hamster PrPC. All assemblies, except the bovine ones, were fully pathogenic on the primary passage, causing clinical disease, PrPSc brain deposition, and spongiform degeneration. They exhibited divergent adaptation processes and strain properties upon subsequent passage. Assemblies of hamster origin propagated without apparent need for adaptation, those of mouse origin adapted abruptly, and those of human origin required serial passages for optimal fitness. Molecular analyses revealed the presence of endogenously truncated PrPSc species in the resulting synthetic strains that lack the 90–140 amino acid region considered crucial for infectivity. In conclusion, rPrP assemblies provide a facile means of generating novel prion strains with adaptative/evolutive properties mimicking genuine prions. The PrP amino acid backbone is sufficient to encode different strains with specific adaptative properties, offering insights into prion transmission and strain diversity.

Generating A Prion With Bacterially Expressed Recombinant Prion Protein

Expression of PrP(C) As HIS-fusion Form in a Baculovirus System and Conversion of Expressed PrP-sen to PrP-res in a Cell-Free System.

De Novo Generation of Infectious Prions with Bacterially Expressed Recombinant Prion Protein

Oral Ingestion of Synthetically Generated Recombinant Prion is Sufficient to Cause Prion Disease in Wild-Type Mice.

Protein Misfolding Cyclic Amplification Cross-Species Products of Mouse-Adapted Scrapie Strain 139A and Hamster-Adapted Scrapie Strain 263K with Brain and Muscle Tissues of Opposite Animals Generate Infectious Prions

Spontaneous generation of distinct prion variants with recombinant prion protein from a baculovirus-insect cell expression system

Knockdown of the prion gene expression by RNA interference in bovine fibroblast cells

Recombinant Prion Protein Generating a Prion with Bacterially Expressed

Comparison of 2 synthetically generated recombinant prions.

Convergent generation of atypical prions in knockin mouse models of genetic prion disease

PrP(Sc) of Scrapie 263K Propagates Efficiently in Spleen and Muscle Tissues with Protein Misfolding Cyclic Amplification.

Mutant D178N Prion Protein Converts Spontaneously in RT-QuIC Assay

Development of a methodology for large-scale production of prions for biological and structural studies

Direct Observation Of Murine Prion Protein Replication In Vitro

Exploration of the main sites for the transformation of normal prion protein (PrP<sup>C</sup>) into pathogenic prion protein (PrP<sup>sc</sup>)

Exploration Of The Main Sites For The Transformation Of Normal Prion Protein (Prpc) Into Pathogenic Prion Protein (Prpsc)

Probing the origin of prion protein misfolding via reconstruction of ancestral proteins

Generation of Genetic Engineering Monoclonal Antibodies Against Prion Protein

Establishment of Hamster- and Human-Prnp Transgenic Mice.

Using Protein Misfolding Cyclic Amplification Generates a Highly Neurotoxic PrP Dimer Causing Neurodegeneration

Species barrier as molecular basis for adaptation of synthetic prions with N‐terminally truncated PrP